Brief: 10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million
06/08/2026 21:03
BRIEF-10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million Aug 06 (Reuters) - 10X Genomics Q2 operating income USD -19.6 million.
- Q2 net income USD -17.9 million
- Q2 gross margin 74%
- outlook FY revenue USD 610-630 million vs. IBES estimate USD 613.9 million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences